Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Research Reports

Contraceptives Market: Rising Consumer Awareness to Support Growth of Market

Untitled design 1 7 2 - Global Banking | Finance

The global contraceptives market size is expected to reach ~US$ 33,529 Mn by the end of 2029. According to a study by Future Market Insights (FMI), the market will show a steady rise at a CAGR of ~6.2% between 2019 and 2029. According to the report, growing need of population control, increasing incidence of unwanted pregnancies and government’s initiatives drive the contraceptive market forward. It uses unique research methods to offer the most accurate analysis of the market.

The exponentially increasing popularity of birth control measures to control the risk of unintended pregnancies is amplifying the demand for safe and reliable contraceptive solutions. Contraceptives have recorded significant demand over the years due to the sale of intrauterine and contraceptive implants methods, that are permanently being used owing to their effectiveness.

Keeping in mind the role contraceptives play towards population control, most of the regional governments have organized awareness programs regarding the need to use the products and their benefits. For instance, the launch of World Contraceptive Day which is held on the 26 September of each year. This program is supported by internationally recognized authorities like WHO and the United Nations among many

To remain ‘ahead’ of your competitors, request for a sample>>> https://www.futuremarketinsights.com/reports/sample/rep-gb-1091

Contraceptive Pills – the Most Lucrative Product Type

Contraceptive market contains drugs and devices. The devices market holds most the contraceptive market however drugs are anticipated to grow at highest CAGR owing to its beneficial property and easy consuming method. With the advancement of technology, the emergence of drugs have become popular as oral contraceptive pills which has the same purpose as other contraceptive drugs or devices. The simplicity and easy consumable method are expected to make it most popular contraceptive market. The other form of drugs such as topical and injectable contraceptives also witness strong market demand. Furthermore, these contraceptive pills are highly effective and does not interrupt in sex. Even in cases, it has been proved to reduce heavy and painful periods. All these factors and benefits are expected to fuel the sales of contraceptive drugs in the global market.

Market segmentation

The global contraceptive market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

Product Type

  • Contraceptive Drugs
    • Oral Contraceptive Pills
    • Injectables
    • Topical
  • Contraceptive Devices
    • Diaphgrams
    • Sponges
    • Vaginal Rings
    • Subdermal Implants
    • Intrauterine Device
    • Condom

Gender

  • Male
  • Female

Price Range

  • High Range
  • Low / Economy Range

Sales Channel

  • Wholesaler/ Distributor
  • Hypermarket/ Supermarket
  • Specialty Stores
  • Drug & Pharma Stores
  • Convenience Stores
  • Online
  • Others (hospitals, clinics etc.)

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

To receive extensive list of important regions, ask for TOC here >>> https://www.futuremarketinsights.com/ask-question/rep-gb-1091

Who is Winning?

Some of the leading players operating in the contraceptives market are Bayer AGPfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc, Reckitt Benckiser Group plc, Veru Inc., Church & Dwight Co., Inc., Medisafe Distribution Inc., Cooper Surgical, Inc., Mayer Laboratories, Inc., Pfizer,

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post